Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Beat Estimates

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $1.88 per share. This compares to earnings of $1.61 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +19.68%. A quarter ago, it was expected that this specialty pharmaceutical company would post earnings of $1.62 per share when it actually produced earnings of $1.68, delivering a surprise of +3.7%.Over th ...